| Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia H Jetani, A Navarro-Bailón, M Maucher, S Frenz, C Verbruggen, ... Blood, The Journal of the American Society of Hematology 138 (19), 1830-1842, 2021 | 48 | 2021 |
| Short tandem repeats (STRs) as biomarkers for the quantitative follow-up of chimerism after stem cell transplantation: methodological considerations and clinical application A Navarro-Bailón, D Carbonell, A Escudero, M Chicano, P Muñiz, ... Genes 11 (9), 993, 2020 | 24 | 2020 |
| Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia AM Hortal, CL Oeste, C Cifuentes, M Alcoceba, I Fernández-Pisonero, ... Molecular cancer 21 (1), 35, 2022 | 15 | 2022 |
| Co-administration of human MSC overexpressing HIF-1α increases human CD34+ cell engraftment in vivo S Preciado, MS Sirerol-Piquer, S Muntión, L Osugui, GJ Martí-Chillón, ... Stem Cell Research & Therapy 12, 1-12, 2021 | 9 | 2021 |
| Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction A Landeira-Viñuela, C Arias-Hidalgo, P Juanes-Velasco, M Alcoceba, ... Frontiers in immunology 13, 965905, 2022 | 8 | 2022 |
| Therapeutic potential of mesenchymal stromal/stem cells in critical‐care patients with systemic inflammatory response syndrome GJ Martí‐Chillón, S Muntión, S Preciado, L Osugui, A Navarro‐Bailón, ... Clinical and Translational Medicine 13 (1), e1163, 2023 | 4 | 2023 |
| IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia C Syrykh, B Pons-Brun, N Russiñol, H Playa-Albinyana, T Baumann, ... Blood Advances 7 (23), 7384-7391, 2023 | 2 | 2023 |
| Dinámica del quimerismo en sangre periférica, médula ósea y linajes leucocitarios en el trasplante alogénico de progenitores hematopoyéticos A Navarro Bailón Universidad Complutense de Madrid, 2020 | 2 | 2020 |
| Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma A Navarro-Bailón, C Jiménez, S Alonso-Álvarez, M Alcoceba, ... Hematological oncology 37 (2), 215-218, 2019 | 2 | 2019 |
| Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... EClinicalMedicine 65, 2023 | 1 | 2023 |
| Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution A Landeira-Viñuela, M Alcoceba-Sanchez, A Navarro-Bailón, ... Cancers 15 (3), 891, 2023 | 1 | 2023 |
| Eltrombopag increases the hematopoietic supporting ability of mesenchymal stem/stromal cells S Muntión, S Preciado, E Sánchez-Luis, L Corchete, M Díez-Campelo, ... Therapeutic Advances in Hematology 13, 20406207221142137, 2022 | 1 | 2022 |
| Real-world evidence on therapeutic strategies and treatment-sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research … T Chatzikonstantinou, L Scarfo, C Demosthenous, J Kotaskova, ... Blood 138 (Supplement 1), 2635-2635, 2021 | 1 | 2021 |
| A novel quantitative PCR approach targeting insertion/deletion polymorphisms (indel-PCR) for chimerism quantification: finally high sensitivity and quantification capacity together A Navarro-Bailón, C Martinez-Laperche, D Carbonell, E Buces, ... Blood 126 (23), 4277, 2015 | 1 | 2015 |
| Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells A Navarro-Bailón, M López-Parra, Á Veiga-Vaz, EM Villarón, ... Cytotherapy, 2024 | | 2024 |
| Longitudinal Transcriptomic Analysis of CAR-T Cells at Single-Cell Level Allows the Identification of Molecular Mechanisms Promoting Long-Term CAR-T Cell Persistence in MM JR Rodriguez-Madoz, L Jordana-Urriza, G Serrano, A Oliver-Caldes, ... Blood 142 (Supplement 1), 2069-2069, 2023 | | 2023 |
| Sequential Scmultiomics of In Vivo CAR-T Cells Allows Characterization of Transcriptional Differences between Patients, and Identifies IL10 As a Potential Mechanism of … JR Rodriguez-Madoz, L Jordana-Urriza, G Serrano, A Oliver-Caldes, ... Blood 142, 3433, 2023 | | 2023 |
| Effects of dietary supplementation with a ferulic acid-rich bioactive component of wheat bran in a murine model of graft-versus-host disease S Preciado, C Martínez-Villaluenga, D Rico, S Muntión, ... Nutrients 15 (21), 4582, 2023 | | 2023 |
| S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY. T Chatzikonstantinou, L Scarfò, G Karakatsoulis, E Minga, D Chamou, ... HemaSphere 7, e24596f8, 2023 | | 2023 |
| Immunotherapy: HIGH INCIDENCE OF CYTOPENIAS AFTER COMMERCIAL CAR-T CELL THERAPY IN A REAL-WORLD SETTING: UTILITY OF THE CAR-HEMATOTOX INDEX A Navarro-Bailon, A Martin, V Martin-Mendez, L Prieto, E Perez-Lopez, ... Cytotherapy 25 (6), S248-S250, 2023 | | 2023 |
